97331 ⎘
Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME
#2ENGINEERED CASCADE COMPONENTS AND CASCADE COMPLEXES
#3ANTI-CANCER STRAIN EXPRESSING STREP-TAG, ANTI-CANCER COMPOSITION USING THE SAME, ANTI-CANCER ADJUVANT AND TUMOR IMAGING AGENT
#4METHODS AND COMPOSITIONS REGARDING CYCLIC PEPTIDES FOR USE WITH ANTIBODIES AND ANTIBODY FRAGMENTS
#5MUTANT CSGG PORES
#6PROTEIN PURIFICATION
#7PREFUSION RSV F PROTEINS AND THEIR USE
#8PREFUSION RSV F PROTEINS AND THEIR USE
#9BIOLOGICAL NANOPORES HAVING TUNABLE PORE DIAMETERS AND USES THEREOF AS ANALYTICAL TOOLS
#10COMPOSITE LIPID NANOPARTICLE AND PREPARATION METHOD THEREOF, RNA VACCINE, DRUG AND USE
#11MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#12RSV F Protein Mutants
#13MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#14PLATFORM TECHNOLOGY FOR BISPECIFIC ANTIGENBINDING PROTEINS
#15MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#16SINGLE MOLECULE NANOPORE SEQUENCING METHOD
#17ERYTHROCYTE-BINDING THERAPEUTICS
#18A PRODUCTION OF A PURIFIED MODIFIED BACTERIAL HYALURONIDASE POLYPEPTIDE, PHARMACEUTICAL COMPOSITIONS AND THEIR USES
#19ANTIBODY SPECIFICALLY BINDING TO STREP-TAG II TAG AND USE THEREOF
#20CELL-FREE METHODS AND COMPOSITIONS COMPRISING TAGLESS THERAPEUTIC HORMONES
#21APPLICATION OF MULTIMER IN DETECTION AND PREPARATION OF CAR-EXPRESSING CELL
#22PROTEIN SCREENING AND DETECTION METHOD
#23CD99-targeting chimeric antigen receptor and application thereof
#24RECRUITMENT METHODS AND COMPOUNDS, COMPOSITIONS AND SYSTEMS FOR RECRUITMENT
#25ERYTHROCYTE-BINDING THERAPEUTICS
#26FUSION PROTEINS COMPRISING SARS-COV-2 RECEPTOR BINDING DOMAIN
#27SYSTEMS AND METHODS FOR THE PREPARATION OF PEPTIDE-MHC-I COMPLEXES WITH NATIVE GLYCAN MODIFICATIONS
#28Prefusion RSV F proteins and their use
#29MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#30BIOCATALYTICAL COMPOSITION AND USE FOR GENERATION OF IMMUNOLIGAND-PAYLOAD CONJUGATES
#31MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME
#32Prefusion RSV F proteins and their use
#33METHODS FOR TARGET RELEASE FROM INTEIN COMPLEXES
#34DUAL-AFFINITY PROBES FOR ANALYTE DETECTION
#35HUMAN METAPNEUMOVIRUS VACCINES
#36LABELED AVIDIN AND METHODS FOR SEQUENCING
#37RSV F Protein Mutants
#38IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
#39CELL SURFACE CONJUGATES AND RELATED CELL COMPOSITIONS AND METHODS
#40ENGINEERED TRIMERIC CD70 PROTEINS AND USES THEREOF
#41DAP10/DAP12 FUSION POLYPEPTIDES
#42ENGINEERED T CELLS AND USES THEREFOR
#43Proximity-based sortase-mediated protein purification and ligation
#44COMBINATION OF REVERSIBLE AND IRREVERSIBLE CELL LABELING FOR ANALIZING RECEPTOR-LIGAND KOFF RATE
#45Tagged chimeric effector molecules and receptors thereof
#46MUL TISPECIFIC PROCHEMOKINE THERAPEUTIC PROTEINS (PARK) AND METHOD OF MAKING AND USING THEREOF
#47Prefusion RSV F proteins and their use
#48STREPTAVIDIN MUTEINS AND METHODS OF USING THEM
#49N- and C-terminal tandem tag system for purification
#50Multimeric IL-15 soluble fusion molecules and methods of making and using same
#51METHODS AND SYSTEMS FOR CONTROLLING THE AGONISTIC PROPERTIES OF ANTIBODY VARIABLE DOMAINS BY LIGHT
#52Biological nanopores having tunable pore diameters and uses thereof as analytical tools
#53Mutant CsgG pores
#54A DOUBLE PEPTIDE TAG COMBINING REVERSIBILITY AND FLEXIBLE FUNCTIONALIZATION
#55Erythrocyte-binding therapeutics
#56Chimeric antigen receptor and application thereof
#57IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
#58CELL SORTING SYSTEMS AND METHODS OF USE
#59Recruitment methods and compounds, compositions and systems for recruitment
#60Modified cascade ribonucleoproteins and uses thereof
#61LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE
#62SYSTEMS AND METHODS FOR THE PREPARATION OF PEPTIDE-MHC-I COMPLEXES WITH NATIVE GLYCAN MODIFICATIONS
#63SOLUBILITY ENHANCING PROTEIN EXPRESSION SYSTEMS
#64Streptavidin muteins and methods of using them
#65Engineered cascade components and cascade complexes
#66Erythrocyte-binding therapeutics
#67SINGLE-CHAIN CD27-RECEPTOR AGONIST PROTEINS
#68Nanobodies suitable for neuron regeneration therapy
#69SINGLE-CHAIN CD40-RECEPTOR AGONIST PROTEINS
#70LENTIVIRAL VECTORS FOR REGULATED EXPRESSION OF A CHIMERIC ANTIGEN RECEPTOR MOLECULE
#71Engineered cascade components and cascade complexes
#72Modified cascade ribonucleoproteins and uses thereof
#73Cell surface conjugates and related cell compositions and methods
#74Engineered cascade components and cascade complexes
#75Proximity-based sortase-mediated protein purification and ligation
#76Tagged chimeric effector molecules and receptors thereof
#77Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#78Light single-chain fusion polypeptides, encoding nucleic acid molecules and host cells
#79A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#80Multimeric IL-15 soluble fusion molecules and methods of making and using same
#81Multimeric IL-15 soluble fusion molecules and methods of making and using same
#82Single-chain glucocorticoid-induced tumor necrosis factor receptor (GITR) receptor agonist proteins
#83Antigen-specific tolerance and compositions for induction of same
#84Engineered cascade components and cascade complexes
#85Modified cascade ribonucleoproteins and uses thereof
#86Modified biotin, streptavidin mutant, and usage of them
#87Mutant pores
#88Light-gated signaling modulation
#89Erythrocyte-binding therapeutics
#90Fusion molecules
#91Amino acid sequence presenting fusion polypeptide and its use
#92DNA polymerase variant and application thereof
#93Superkine
#94Recombinant prefusion RSV F proteins and uses thereof
#95Biological nanopores for biopolymer sensing and sequencing based on FRAC actinoporin
#96Protein screening and detection method
#97Combination of reversible and irreversible cell labeling for analizing receptor-ligand krate
#98Antimicrobial biopolymer compositions, methods of synthesis, and applications of use
#99METHODS AND COMPOSITIONS RELATED TO ANTIGEN PRESENTING PROTEINS
#100CD40L single-chain fusion polypeptides and encoding nucleic acids
#101Botulinum neurotoxin and its derivatives
#102Immunotherapies employing self-assembling vaccines
#103RSV F protein mutants
#104Streptavidin muteins and methods of using them
#105Substitutions-modified prefusion RSV F proteins and their use
#106PROTEIN VARIANTS FOR USE AS LIPID BILAYER-INTEGRATED NANOPORE, AND METHODS THEREOF
#107IN SITU AND IN VIVO ANALYSIS OF CHROMATIN INTERACTIONS BY BIOTINYLATED DCAS9 PROTEIN
#108Cellular libraries of peptide sequences (CLiPS) and methods of using the same
#109Method of treating neoplasia with a multimeric IL-15 soluble fusion molecule
#110CD27 ligand (CD27L) single-chain fusion polypeptides
#111CD27L collectin fusion proteins and encoding nucleic acids
#112Streptavidin muteins and methods of using them
#113Prefusion RSV F proteins and their use
#114Methods for non-covalent Fc-domain-containing protein display on the surface of cells and methods of screening thereof
#115Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#116Single-chain TL1A receptor agonist proteins
#117Single-chain glucocorticoid-induced tumor necrosis factor receptor (GITR) agonist proteins
#118Single-chain CD27-receptor agonist proteins
#119Method of inducing an immune response against human immunodeficiency virus comprising administering immunogenic compositions comprising authentic trimeric HIV-1 envelope glycoproteins containing a long linker and tag
#120Antigen-specific tolerance and compositions for induction of same
#121Compositions for generation of immune tolerance to specific antigens
#122Compositions for inducing antigen-specific tolerance
#123RSV F protein mutants
#124MUTANT CSGG PORES
#125Modified cascade ribonucleoproteins and uses thereof
#126Erythrocyte-binding therapeutics
#127Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#128Fusion Proteins for Modulating Regulatory and Effector T Cells
#129Single-chain CD40-receptor agonist proteins
#130Method of purifying authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag
#131Engineered T cells and uses therefor
#132Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
#133Glucocorticoid-induced tumor necrosis factor receptor ligand (GITRL) single-chain fusion polypeptides
#134Capping modules for designed ankyrin repeat proteins
#135Biosensor system for the rapid detection of analytes
#136Biosensor system for the rapid detection of analytes
#137Biosensor system for the rapid detection of analytes
#138Nanobodies suitable for neuron regeneration therapy
#139Mutant CsgG pores
#140Tagged chimeric effector molecules and receptors thereof
#141Method and means for purifying retroviral vectors
#142RSV F protein mutants
#143Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
#144Modified biotin, streptavidin mutant, and usage of them
#145Protein isolation
#146GITRL-collectin fusion proteins and encoding nucleic acids
#147Erythrocyte-binding therapeutics
#148Biomolecule-releasing cell and selection thereof by means of a surface protein
#149Fusion molecules
#150Methods for reducing immune responses
#151Multimeric IL-15 soluble fusion molecules and methods of making and using same
#152Compositions for inducing antigen-specific tolerance
#153Methods for induction of antigen-specific immune tolerance
#154Compositions for generating immune tolerance by targeting erythrocytes
#155Fusion proteins for modulating regulatory and effector T cells
#156Biosensor system for the rapid detection of analytes
#157Approach to produce HIV-1 GP140 envelope protein trimers
#158CD27 single chain molecules and encoding nucleic acids
#159Streptavidin muteins and methods of using them
#160Approach to produce HIV-1 GP140 envelope protein trimers
#161Method of purifying authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tag
#162Authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag
#163Authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tag
#164Designed repeat proteins binding to serum albumin
#165Multimeric IL-15 soluble fusion molecules and methods of making and using same
#166Modified cascade ribonucleoproteins and uses thereof
#167Means and methods for diagnosing and treating multiple sclerosis
#168Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VHH domain
#169Heat stable keratinase and use thereof
#170Amino acid sequence presenting fusion polypeptide and its use
#171Antibody specifically binding to insulin-like growth factor-1
#172Capping modules for designed ankyrin repeat proteins
#173Prefusion RSV F proteins and their use
#174IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES
#175Cellular libraries of peptide sequences (CLiPS) and methods of using the same
#176Modified biotin-binding protein
#177Membrane-integrated viral DNA-packaging motor protein connector biosensor for DNA sequencing and other uses
#178CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
#179Diagnostic method for detecting an autoimmune disease
#180NOVEL FAR RED FLUORESCENT PROTEIN
#181Disulfide stabilized foldon polypeptides
#182FUSION PROTEINS FORMING TRIMERS
#183ADAPTER MOLECULE CAPABLE OF REVERSIBLY EQUIPPING A FUSION PROTEIN CARRYING AN OLIGOHISTIDINE AFFINITY TAG WITH A FURTHER AFFINITY TAG AND METHODS OF USING THE SAME
#184BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in oncology
#185CHIMERIC PROTEINS FOR TREATMENT OF DISEASES
#186Protein isolation
#187Polyvalent chimeric OSPC vaccinogen and diagnostic antigen
#188MOLECULAR AND CELLULAR IMAGING USING ENGINEERED HEMODYNAMIC RESPONSES
#189Erythrocyte-binding therapeutics
#190porins and toxins and related methods
#191Method of reversibly staining a target cell
#192ND2 peptides and methods of treating neurological disease
#193Multimeric IL-15 soluble fusion molecules and methods of treating neoplasia and HIV using same
#194Multimeric IL-15 soluble fusion molecules and methods of making and using same
#195Amino acid sequence presenting fusion polypeptide and its use
#196Polypeptides
#197Fusion proteins forming trimers
#198Multimeric IL-15 soluble fusion molecules and methods of using same
#199Antibody specifically binding to insulin-like growth factor-1
#200Means and methods for diagnosing and treating multiple sclerosis
#201BLID; a novel protein domain for interaction with the Bcl-2 family of proteins
#202Spider silk fusion protein structures for binding to an organic target
#203Capping modules for designed ankyrin repeat proteins
#204Designed repeat proteins binding to serum albumin
#205Self-Assembled Bead-Based Multiplexed Assay For Antigen-Specific Antibodies
#206RECOMBINANT MULTIMERIC INFLUENZA PROTEINS
#207Polypeptides
#208Modified biotin-binding protein
#209Erythrocyte-binding therapeutics
#210Multimeric IL-15 soluble fusion molecules and methods of making and using same
#211FUNCTIONAL HEAVY CHAIN ANTIBODIES, FRAGMENTS THEREOF, LIBRARY THEREOF AND METHODS OF PRODUCTION THEREOF
#212Compositions comprising natriuretic peptides and methods of use thereof
#213Method for producing serratia marcescens nuclease using a bacillus expression host
#214Bacteriophage adhesion proteins
#215Fusion proteins forming trimers
#216Erythrocyte-binding therapeutics
#217Mucin derived polypeptides
#218Compositions and method for CaMKII inhibitors and uses thereof
#219ANTIMICROBIAL COMPOSITIONS, FORMULATIONS AND USES THEREOF
#220FUNCTIONAL HEAVY CHAIN ANTIBODIES, FRAGMENTS THEREOF, LIBRARY THEREOF AND METHODS OF PRODUCTION THEREOF
#221Cognate sampling kinetics
#222Single-chain TNFSF fusion polypeptides
#223Megalin-based delivery of therapeutic compounds to the brain and other tissues
#224Immunotherapies employing self-assembling vaccines
#225METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS
#226PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS
#227Collectin fusion proteins comprising TNF or trail
#228METHODS AND COMPOSITIONS FOR TREATING TUMORS AND METASTASES THROUGH THE MODULATION OF LATEXIN
#229Cellular libraries of peptide sequences (CLiPS) and methods of using the same
#230MEANS AND METHODS FOR ISOLATING AND DETERMINING NOVEL TARGETS FOR THE TREATMENT OF NEURODEGENERATIVE, NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS AND COMPOSITIONS COMPRISING THE SAME
#231Polypeptides having binding affinity for HER2
#232Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
#233Receptor associated protein (RAP) conjugates
#234Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
#235Avidin mutants
#236Polypeptides
#237AMINO ACID SUBSTITUTED MOLECULES
#238PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS
#239Modified human interferon-β polypeptides
#240Methods and compositions for expanding T regulatory cells
#241Modified soluble T cell receptor
#242Cellular libraries of peptide sequences (CLiPS) and methods of using the same
#243Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
#244Process for producing template DNA and process for producing protein in cell-free protein synthesis system with the use of the same
#245Chimeric fusion molecule for analyte detection and quantitation
#246Streptavidin-binding peptide
#247Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents
#248Streptavidin-binding peptides and uses thereof
#249Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to Venezuelan equine encephalitis virus
#250Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
#251Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents
#252Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
#253Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#254Use of B7-H3 as an immunoregulatory agent